Benzinga.com · 2d
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.
Arab Times · 17h
Musk upgrades to Mounjaro, 'King Kong' of weight-loss medications
Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with fewer side effects. It received FDA approval for weight loss in November 2023 under the brand name Zepbound. In the UK, the drug will be available on a limited basis through the NHS starting in April.
Benzinga.com · 1d
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
“While no drug is without side effects, health problems associated with obesity almost certainly exceed the risks of GLP-1 agonists,” Musk said as early as Oct. 2023. GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results